MEGIN Spotlights

Listen to this MEGIN Spotlight with MYndspan co-founder and COO, Caitlin Baltzer, and CSO, Dr. Ben Dunkley. Learn about MYndspan, a service designed to empower consumers about brain health, with a detailed report of brain function following a quick 45-minute on-site appointment for an MEG scan and assessment. Our guests further elaborate on why they are utilizing MEG technology as the main modality for MYndspan scans, and what insights consumers can learn from brain function reports.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

MEGIN was delighted to welcome Nick, Danielle, and Everett Oostveen. We were introduced to the Oostveens by our wonderful customer-partner, and previous Spotlight guest, Dr. Angel Hernandez. Dr. Hernandez is the division chief for pediatric neurology at Corewell Health Helen De Vos Children's Hospital. The Oostveens have kindly agreed to share their epilepsy surgery journey in this Spotlight episode.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

MEGIN was delighted to welcome Emily Portis. We were introduced to Emily at an advocacy event last summer hosted by the Pediatric Epilepsy Surgery Alliance, our wonderful advocacy group partner. After meeting Emily and her daughter Jenna there, she kindly agreed to share her caregiver's perspective on her daughter's epilepsy diagnosis and surgery journey with us and how the family discovered MEG Technology during Jenna's treatment journey.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

A compilation of some of MEGIN's prestigious research customers who utilize MEG Technology in research studies across the globe.

MEGIN welcomed Professor Yokosawa from the Faculty of Health Sciences, and Associate Professor Shiraishi from the Paediatric Neurology Department focusing on epilepsy for this month's spotlight episode. Hokkaido University has two MEG devices, one for clinical use and the other for research use.

Both Sherrie's children have epilepsy, detected at different ages. Sherrie describes how MEG assisted epilepsy drug management to improve seizure control.

Ken's daughter was suspected to have epilepsy in the ER, and was then transferred to an inpatient team under the care of a leading expert in epilepsy. Ken describes the family's journey of discovering MEG Technology and how a relatively quick decision about surgery was made which has allowed Ken's daughter to have an improved quality of life.

MEGIN was delighted to welcome Dr. Lucia Amoruso, an Ikerbasque Researcher at the BCBL, in Spain. Dr. Amoruso leads the line of research focused on the identification of neurophysiological markers supporting language plasticity in brain tumor patients via means of magnetoencephalography (MEG). Polina Timofeeva is a Ph.D. student working with Dr. Amoruso, conducting her thesis in the same field. In addition, BCBL's research activity aims to unravel the neurocognitive mechanisms involved in the acquisition, comprehension, and production of language, with special emphasis on bilingualism and multilingualism.

Dr. Alex Wiesman describes his journey with MEG and how he was first exposed to the technology. We find out about MEG's challenges and its overpowering benefits in his research work.

MEGIN welcomed Dr. Vahe Poghosyan, Head of the MEG department at King Fahd Medical City, National Neuroscience Institute Riyadh, in Saudi Arabia.

KFMC has a strategic location in the heart of Riyadh city, the capital of Saudi Arabia, and is one of the largest and fastest-growing medical complexes in the Middle East with a total capacity of 1200 beds. It has a highly qualified and efficient Technical Management Team. It is also one of the most advanced hospitals in the region.

The team at KFMC is engaged to achieve one goal: making the hospital a benchmark in the medical care, to which all patients from all over the region are referred, for all treatment levels where medical and professional competencies of different disciplines are gathered to provide assistance to patients. KFMC is estimated annually to treat more than 30,000 inpatients and 500,000 outpatients.